Avanish Vellanki, MBA, MBS

Cofounder, Chairman and CEO

Avanish Vellanki is a cofounder of Rain Therapeutics, and is serving as Chairman, and Chief Executive Officer. Avanish was previously a Senior Vice President and Chief Business Officer at Aptose Biosciences. He began his career as an equity research analyst at Bear, Stearns & Co., covering the biotechnology sector, and focusing on the small/mid-cap space before subsequently transitioning to Global Healthcare Investment Banking at Citigroup, where he advised on numerous multi-billion dollar strategic transactions for global biopharmaceutical companies. Avanish then joined the Corporate Development team at Proteolix, acquired by Onyx Pharmaceuticals in 2009 for carfilzomib (Kyprolis).

Avanish is married, with three daughters, and resides in Fremont, California. He enjoys time with his family hiking in Yosemite, and skiing in Tahoe.

Mr. Vellanki received his BA in Biology from Carleton College, his MBS in Biochemistry from the University of Minnesota, and MBA from the University of Minnesota, Carlson School of Management.